CHM Cannabis
Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

If there were any realistic chance that there

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
arvitar Member Profile
 
Followed By 54
Posts 13,926
Boards Moderated 0
Alias Born 01/19/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2018 4:39:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 4:38:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2018 5:23:31 PM
NanoViricides, Inc. Appoints Mr. James Sapirstein to its Board of Directors PR Newswire (US) - 10/29/2018 7:00:00 AM
NanoViricides CEO Dr. Irach Taraporewala Presents a Letter to Shareholders PR Newswire (US) - 10/22/2018 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/19/2018 4:36:17 PM
NanoViricides Has Filed its Annual Report, Company Reports Strong Progress in Advancement of HerpeCide Program PR Newswire (US) - 10/15/2018 7:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 10/12/2018 4:51:39 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/12/2018 6:05:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/11/2018 5:24:24 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 9/28/2018 5:49:02 PM
NanoViricides Inc. to Present at the MicroCap Conference in New York City on October 1 PR Newswire (US) - 9/28/2018 7:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/12/2018 6:05:23 AM
NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th PR Newswire (US) - 9/5/2018 7:00:00 AM
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study PR Newswire (US) - 8/7/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2018 4:44:51 PM
NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO PR Newswire (US) - 7/23/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2018 6:04:09 AM
NanoViricides Provides Update on Recent Events PR Newswire (US) - 7/12/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2018 6:05:20 AM
Progress of NanoViricides' Shingles Drug Program Presented at the 31st International Conference on Antiviral Research PR Newswire (US) - 6/26/2018 7:00:00 AM
NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and I... PR Newswire (US) - 5/22/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/21/2018 4:22:22 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2018 4:33:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/4/2018 6:07:03 PM
arvitar   Thursday, 03/08/18 09:58:46 PM
Re: Nanotoday post# 138140
Post # of 141064 
Quote:
If there were any realistic chance that there would be a positive development or news in the next 13 months, does anyone think Seymour would have left?



This seems painfully obvious, but Seymour's departure is being celebrated as positive progress. Some even believe that "we're going to be slowly trending up now that changes are in the works. "

It was even more glaringly obvious back in 2005 that Diwan and Seymour never believed there was value in any of this. They would have wanted all the resources directly applied towards developing drug candidates had they really believed in it. Instead, they built generational wealth for their families by siphoning off tens of millions of dollars through Theracour.

Yet, there are still investors who truly believe Diwan and Seymour believed their own bullshit at the start. Go figure.

A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist